» Articles » PMID: 31511258

A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid -1 Hydroxylation Using an Untargeted Metabolomic Approach

Overview
Specialty Pharmacology
Date 2019 Sep 13
PMID 31511258
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cytochrome P450 (P450) 2S1 is one of the orphan P450s, known to be expressed but not having a defined function with an endogenous substrate or in drug oxidations. Although it has been clearly demonstrated to catalyze reductive reactions, its role in NADPH-dependent oxidations has been ambiguous. In our efforts to characterize orphan human P450 enzymes, we used an untargeted liquid chromatography-mass spectromterymetabolomic approach with recombinant human P450 2S1 and extracts of rat stomach and intestine, sites of P450 2S1 localization in humans and animals. The search yielded several candidates, including the product 19-hydroxyarachidonic acid. Subsequent O analysis and in vitro studies with commercial arachidonic acid and 19-hydroxyarachidonic acid were used to validate -1 hydroxylation of the former molecule as a NADPH- and O-dependent reaction. Steady-state kinetic assays were done for -1 hydroxylation reactions of P450 2S1 with several other long-chain fatty acids, including arachidonic, linoleic, -linolenic, eicosapentaenoic, and docosapentaenoic acids. Rates of hydroxylation were slow, but no detectable activity was seen with either medium-chain length or saturated fatty acids. P450 2S1 is known to be expressed, at least at the mRNA level, to the extent of some other non-3A subfamily P450s in the human gastrointestinal tract, and the activity may be relevant. We conclude that P450 2S1 is a fatty acid -1 hydroxylase, although the physiologic relevance of these oxidations remains to be established. The metabolomic approaches we employed in this study are feasible for orphan P450s and other enzymes, in regard to annotation of function, in mammals and other organisms. SIGNIFICANCE STATEMENT: An untargeted mass spectrometry approach was utilized to identify -1 hydroxylation of arachidonic acid as an oxidative reaction catalyzed by human cytochrome P450 2S1. The enzyme also catalyzes the relatively slow -1 hydroxylation of several other unsaturated long-chain fatty acids.

Citing Articles

Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.

Guengerich F Pharmacol Rev. 2024; 76(6):1104-1132.

PMID: 39054072 PMC: 11549934. DOI: 10.1124/pharmrev.124.001173.


Catalytic enhancements in cytochrome P450 2C19 by cytochrome .

Lee G, Kim V, Lee S, Jeong E, Kim C, Lee Y Toxicol Res. 2024; 40(2):215-222.

PMID: 38525137 PMC: 10959859. DOI: 10.1007/s43188-023-00219-8.


Ninety-eight semesters of cytochrome P450 enzymes and related topics-What have I taught and learned?.

Guengerich F J Biol Chem. 2024; 300(2):105625.

PMID: 38185246 PMC: 10847173. DOI: 10.1016/j.jbc.2024.105625.


A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson's disease.

Hartz P, Fehlmann T, Wagenpfeil G, Unger M, Bernhardt R Front Pharmacol. 2023; 13:1094265.

PMID: 36744208 PMC: 9892771. DOI: 10.3389/fphar.2022.1094265.


Human Orphan Cytochromes P450: An Update.

Molina-Ortiz D, Torres-Zarate C, Santes-Palacios R Curr Drug Metab. 2022; 23(12):942-963.

PMID: 36503398 DOI: 10.2174/1389200224666221209153032.


References
1.
Kumarakulasingham M, Rooney P, Dundas S, Telfer C, Melvin W, Curran S . Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res. 2005; 11(10):3758-65. DOI: 10.1158/1078-0432.CCR-04-1848. View

2.
Nishida C, Lee M, de Montellano P . Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol. 2010; 78(3):497-502. PMC: 2939484. DOI: 10.1124/mol.110.065045. View

3.
Fromel T, Kohlstedt K, Popp R, Yin X, Awwad K, Barbosa-Sicard E . Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques. Basic Res Cardiol. 2012; 108(1):319. DOI: 10.1007/s00395-012-0319-8. View

4.
Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

5.
Downie D, McFadyen M, Rooney P, Cruickshank M, Parkin D, Miller I . Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res. 2005; 11(20):7369-75. DOI: 10.1158/1078-0432.CCR-05-0466. View